While RAS itself is not typically mutated, the RAS pathway is genetically altered in glioblastoma, astrocytoma, and high- and low-grade glioma, with NF1 loss being quite common in up to 17% of glioblastoma [109]. This evidence concerns the gene NF1 and glioblastoma.